Skip to main content

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

Recruiting · Phase 2 · NCT07285018

Conditions: Diabetic Peripheral Neuropathic Pain

At a glance

Research payments reported, 2025
$35,958
U.S. investigators named
35
Sites paid
32
Planned or actual enrollment
150

About the trial

Sponsor
Eli Lilly and Company
Tested
LY4065967 (drug), Placebo (drug)
Dates
Started 2026-02-16; completion 2027-07
Results posted
Not yet

The purpose of this study is to test the safety and efficacy of study drug LY4065967 for the treatment of diabetic peripheral neuropathic pain (DPNP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.

From ClinicalTrials.gov, last updated 2026-11-04. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $35,958 in research payments for this study in 2025 (35 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Artemis Headlands LLC $2,042
  • Delricht LLC $2,042
  • K2 Medical Research LLC $2,042
  • Northwest Clinical Research Center $1,247
  • Central Research Associates, Inc $1,021
  • Clinical Research Advantage $1,021
  • Cotton Oneil Msd of Stormont Vail Healthcare $1,021
  • Altoona Center for Clinical Research PC $1,021
  • Rochester Clinical Research Inc $1,021
  • Precision Clinical Research LLC $1,021
  • Christiana Hospital, DE $1,021
  • Re Cognition Health Corporation $1,021
  • Suncoast Research $1,021
  • Medvadis Research Corp LLC $1,021
  • Lucida Clinical Trials $1,021
  • Conquest Research LLC $1,021
  • Bradenton Research Center Inc $1,021
  • Chase Medical Research LLC $1,021
  • Clinvest Research LLC $1,021
  • Future Search Trials of Dallas LP $1,021
  • Desert Med Group DBA Desert Oasis Hlthcare $1,021
  • New Horizon Research Center $1,021
  • Driscoll Childrens Hospital, TX $1,021
  • Renstar Inc $1,021
  • Rainier Clinical Research Center Inc $1,021
  • Meta Medical Research Institute LLC $1,021
  • Studymetrix Research LLC $1,021
  • Suncoast Clinical Research $1,021
  • Lillestol Research LLC $1,021
  • Meridien Research $1,021
  • Charter Research LLC $1,021
  • North Georgia Clinical Research $1,021

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.